What is the current Dexketoprofen market size?

The current Dexketoprofen market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Dexketoprofen market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Dexketoprofen market?

Increasing demand for pain management and growing prevalence of chronic pain drive the market.

What are the major challenges facing the Dexketoprofen market?

Stringent regulations and side effects of Dexketoprofen are major challenges.

Which regions are the leaders in the Dexketoprofen market?

North America and Europe are the leading regions in the Dexketoprofen market.

Who are the top companies in the Dexketoprofen market?

Top companies include Menarini, Sanofi, and Merck.

What are the future opportunities in the Dexketoprofen market?

Increasing demand in emerging economies and new product launches offer future opportunities.

How does technology impact the Dexketoprofen market?

Advances in drug delivery technology improve efficacy and patient compliance.

What is the current regulatory landscape for the Dexketoprofen market?

Regulatory bodies like FDA and EMA monitor the market with strict guidelines.

What is the future outlook for the Dexketoprofen market?

The future outlook is positive with growing demand and new product developments.

Dexketoprofen Market 2026: Primary Research + Expert Analysis

Dexketoprofen by Application (Hospitals, Clnincs, Others), by Types (Tablet, Capsule, Gel, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2.5 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2.5 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Dexketoprofen Market Size | CAGR 5.2 Forecast 2033

Dexketoprofen Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2.5 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2.5 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Dexketoprofen Market Overview

The Dexketoprofen market refers to the global industry involved in the development, production, and distribution of Dexketoprofen, a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. As a key player in the pharmaceutical industry, the Dexketoprofen market size is estimated to be around $1.3 billion in 2025. The growth outlook for the Dexketoprofen market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2026 to 2033, driven by factors such as an increasing industry expansion into emerging markets and a growing demand for effective pain management solutions.

Loading chart…

The Dexketoprofen market is driven by several key forces, including technology shifts towards more efficient manufacturing processes, regulations governing the approval and sale of pharmaceuticals, and changing consumer behavior towards more convenient and effective pain management solutions. The largest region for the Dexketoprofen market is currently North America, while the fastest-growing region is Asia Pacific, driven by increasing demand from emerging markets such as China and India. As the market continues to evolve, it is likely that we will see increased competition and innovation, particularly in the development of new formulations and delivery systems.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 million
Revenue forecast in 2033	3.75 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; BEC Chemicals; Hanmi Pharm; Menarini Group; Zhejiang Jiuzhou Pharmaceutical; Hubei Xunda Pharmaceutical; PKU Healthcare; Mudanjiang Lingtai Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Dexketoprofen market is poised for significant growth, driven by various factors that are shaping its trajectory. Understanding these dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing demand for non-steroidal anti-inflammatory drugs (NSAIDs) is driving the Dexketoprofen market size, as patients seek effective pain management solutions with minimal side effects.

Advances in pharmaceutical technology have improved the formulation and delivery of Dexketoprofen, enhancing its efficacy and patient compliance, which in turn contributes to the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements and the need for extensive clinical trials before market approval can hinder the growth of new Dexketoprofen products, affecting the overall Dexketoprofen market.

The presence of generic alternatives and intense competition among pharmaceutical companies can lead to pricing pressures, impacting revenue growth and profitability in the Dexketoprofen market size.

Opportunities2 items

Emerging markets in Asia and Latin America offer significant opportunities for expansion, driven by increasing healthcare expenditure and a growing demand for effective pain management treatments, contributing to the growth forecast.

The development of novel formulations and combination therapies presents opportunities for pharmaceutical companies to differentiate their products and capture a larger share of the Dexketoprofen market.

Challenges2 items

The risk of side effects associated with NSAIDs, including gastrointestinal issues and cardiovascular events, poses a significant challenge to the Dexketoprofen market, necessitating careful patient selection and monitoring.

Fluctuations in raw material prices and supply chain disruptions can impact the production costs and availability of Dexketoprofen, affecting the Dexketoprofen market size and the ability of manufacturers to meet demand.

Market Segmentation

Loading chart…

The Dexketoprofen segmentation by Application includes various categories that contribute to the overall market size. This segmentation is crucial in understanding the market taxonomy and identifying areas of growth. The applications of Dexketoprofen include pain management, inflammation treatment, and other medical uses. Each application has a significant impact on the market size, with pain management being the largest contributor.

The Types of Dexketoprofen include intravenous, oral, and topical formulations. These subtypes have different market shares, with oral formulations being the most widely used. The market size of each subtype varies based on factors such as patient preference, disease severity, and geographical location. Understanding these subtypes is essential for Dexketoprofen market analysis and forecasting.

Dexketoprofen Segmentation Breakdown9 items

Application

Hospitals

Clnincs

Others

Types

Tablet

Capsule

Gel

Others

Regional Insights

Loading chart…

The Dexketoprofen market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and the fastest-growing region, driven by increasing adoption of Dexketoprofen in countries such as China and India. Key drivers for Asia Pacific include government policies supporting the development of the pharmaceutical industry, investments in research and development, and a large demographic population with a high prevalence of pain-related disorders.

In North America, key drivers include a mature ecosystem with a well-established pharmaceutical industry, a high level of infrastructure development, and a significant investment in research and development. Europe is driven by a strong regulatory framework, a high level of adoption of Dexketoprofen, and a large demographic population with a high prevalence of pain-related disorders. Latin America and Middle East & Africa are expected to experience moderate Dexketoprofen market growth, driven by increasing adoption and investment in the pharmaceutical industry.

Regional Forecast5 items

North America: 20% of the global market, driven by a mature ecosystem and high investment in research and development

Europe: 25% of the global market, driven by a strong regulatory framework and high adoption of Dexketoprofen

Asia Pacific: 40% of the global market, driven by government policies and a large demographic population

Latin America: 5% of the global market, driven by increasing adoption and investment in the pharmaceutical industry

Middle East & Africa: 10% of the global market, driven by increasing adoption and investment in the pharmaceutical industry

Competitive Landscape

The Dexketoprofen market is moderately consolidated, driven by a mix of global players and local/regional companies. The Dexketoprofen competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Boehringer Ingelheim: regional expansion

BEC Chemicals: vertical integration

Hanmi Pharm: premium pricing

Menarini Group: OEM tie-ups

Zhejiang Jiuzhou Pharmaceutical: innovation pipeline

Hubei Xunda Pharmaceutical: local manufacturing

Key Dexketoprofen Companies8 items

Boehringer Ingelheim

BEC Chemicals

Hanmi Pharm

Menarini Group

Zhejiang Jiuzhou Pharmaceutical

Hubei Xunda Pharmaceutical

PKU Healthcare

Mudanjiang Lingtai Pharmaceuticals

Market Ecosystem

The Dexketoprofen ecosystem spans across upstream, midstream, and downstream segments, encompassing various participants that create and capture value. It begins with technology providers and suppliers, followed by integrators, channels, and ultimately, end users. Understanding the Dexketoprofen ecosystem requires a thorough value chain analysis, as it reveals how different components interact and influence one another.

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Dexketoprofen products

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — consume Dexketoprofen products

Regulators/standards bodies — oversee safety and efficacy standards

Data/analytics providers — provide insights on market trends and consumer behavior

The flow of value within the Dexketoprofen ecosystem is influenced by control points, such as regulatory approvals and partnerships between manufacturers and distributors. Dependency risks, including input constraints and standards compliance, can impact the ecosystem's efficiency. Moreover, switching costs and interoperability requirements may affect the ability of participants to adapt to changes in the market. The ecosystem's dynamics can also vary by region, with different areas having distinct regulatory frameworks and market demands.

Recent Industry Insights

The Dexketoprofen industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been formed to enhance research and development capabilities, while mergers and acquisitions have led to market consolidation. Additionally, several product launches have taken place, introducing new formulations and delivery methods. Regulatory changes have also impacted the industry, with updated guidelines for the use of Dexketoprofen in various therapeutic areas.

Furthermore, there has been a notable shift in consumer trends, with a growing preference for non-steroidal anti-inflammatory drugs like Dexketoprofen. Funding rounds and expansions have also been announced, enabling companies to invest in new technologies and manufacturing facilities. These developments are expected to drive growth in the Dexketoprofen market, with the industry poised for continued innovation and evolution.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Dexketoprofen market outlook. The market exhibits moderate attractiveness, driven by its application in pain management. The competitive intensity is high, with several key players operating in the space. The long-term outlook appears promising, with growing demand for effective pain management solutions. The innovation landscape is characterized by ongoing research into new formulations and delivery methods. However, the demand-supply balance may be affected by regulatory factors and supply chain disruptions. Key risk factors include intense competition, pricing pressure, and stringent regulatory requirements.

11 items

1. Executive Summary

2. Dexketoprofen Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Dexketoprofen Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Dexketoprofen Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clnincs

6.1.3. Others

6.2. Global Dexketoprofen Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Tablet

6.2.2. Capsule

6.2.3. Gel

6.2.4. Others

6.3. Global Dexketoprofen Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Dexketoprofen Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Dexketoprofen Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Dexketoprofen Market Competition by Key Manufacturers

8.1. Global Dexketoprofen Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Dexketoprofen: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boehringer Ingelheim

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BEC Chemicals

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Hanmi Pharm

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Menarini Group

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Zhejiang Jiuzhou Pharmaceutical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hubei Xunda Pharmaceutical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. PKU Healthcare

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mudanjiang Lingtai Pharmaceuticals

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Dexketoprofen Market

Figure 4: Global Dexketoprofen Market: Drivers

Figure 5: Global Dexketoprofen Market: Challenges

Figure 6: Global Dexketoprofen Market: Trends

Figure 7: Global Dexketoprofen Market: Opportunity

Figure 8: Global Dexketoprofen Market: Restraint

Figure 9: Global Dexketoprofen Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Dexketoprofen Market Value (USD Million) By Region

Figure 15: Global Dexketoprofen Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Dexketoprofen Market Value (USD Million) By Region

Figure 23: Global Dexketoprofen Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Dexketoprofen Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Dexketoprofen Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Dexketoprofen Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Dexketoprofen Market Value (USD Million) By Region

Table 10: Global Dexketoprofen Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Dexketoprofen Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Dexketoprofen Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Dexketoprofen Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boehringer Ingelheim Basic Information And Sales Area

Table 31: Boehringer Ingelheim. Products Portfolio

Table 32: BEC Chemicals Basic Information And Sales Area

Table 33: BEC Chemicals. Products Portfolio

Table 34: Hanmi Pharm Basic Information And Sales Area

Table 35: Hanmi Pharm. Products Portfolio

Table 36: Menarini Group Basic Information And Sales Area

Table 37: Menarini Group. Products Portfolio

Table 38: Zhejiang Jiuzhou Pharmaceutical Basic Information And Sales Area

Table 39: Zhejiang Jiuzhou Pharmaceutical. Products Portfolio

Table 40: Hubei Xunda Pharmaceutical Basic Information And Sales Area

Table 41: Hubei Xunda Pharmaceutical. Products Portfolio

Table 42: PKU Healthcare Basic Information And Sales Area

Table 43: PKU Healthcare. Products Portfolio

Table 44: Mudanjiang Lingtai Pharmaceuticals Basic Information And Sales Area

Table 45: Mudanjiang Lingtai Pharmaceuticals. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Dexketoprofen Market Value (USD Million) By Region

Table 51: Global Dexketoprofen Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Dexketoprofen Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 million
Revenue forecast in 2033	3.75 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; BEC Chemicals; Hanmi Pharm; Menarini Group; Zhejiang Jiuzhou Pharmaceutical; Hubei Xunda Pharmaceutical; PKU Healthcare; Mudanjiang Lingtai Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options